WATERLOO, Ontario -Nov. 18, 2010 -- DALSA Corporation [TSX: DSA], a global leader in digital image sensing technology, today introduced the first in a family of dynamic CMOS X-ray detector panels. The new Xineos represents the industry's first standard CMOS flat-panel detector to deliver high speed, low dose imaging without compromises in resolution. The Xineos 1313 will be showcased at the upcoming RSNA 2010 show, which will be held Nov. 28 - Dec. 3, at McCormick Place in Chicago. DALSA will showcase its latest advances in image sensor technology for medical imaging and dental radiography in North Building - Hall B: Booth #8722.
DALSA's CMOS Technology
As a leader in CMOS innovation, DALSA developed Xineos to deliver superior sensitivity and signal-to-noise performance compared to other standard technologies at equal X-ray dose conditions. CMOS image detectors offer numerous advantages including the ability to record faint image details at higher resolutions--allowing for the diagnostics of medical anomalies at earlier stages, and significantly increasing the probability of early intervention, patient recovery, and reduced treatment costs.
"With the introduction of DALSA's Xineos line of digital imaging X-ray panels, we are leveraging our CMOS technology to maximize the signal and minimize sources of noise in X-ray imaging," states Bryan Delodder, Xineos product manager at DALSA. "In low dose conditions where competing products fail to distinguish faint signals due to noise, our advanced CMOS detectors excel to deliver the clearest images possible."
Focus On Low Dose Applications
In dental applications DALSA's Xineos-1313-EO is designed to operate at full resolution for both frame-based panoramic imaging, at frame rates exceeding 300 fps, as well as for Medium Field of View (MFOV) Cone Beam CT applications at 30 fps. An optional "Sequence Memory" enables storing an entire CBCT image sequence inside the detector, eliminating the need for rescans due to data acquisition loss during the actual CBCT scanning procedure.
In medical applications the Xineos-1313-FL is optimized for fluoroscopic imaging, offering the highest X-ray sensitivity combined with lowest readout noise. Xineos enables real-time imaging for cardiac, vascular, orthopedic as well as other minimally-invasive procedures that depend on real-time imaging, with minimum patient dose.
Gigabit Ethernet for Simplified Connectivity and Operation
Xineos products are equipped with DALSA's hardware and software implementation of the industry standard GigE Vision® data interface. Xineos can connect almost any computer within minutes to produce low-noise, real-time, high resolution X-ray images.
For more information about Xineos products, please visit the Life Sciences section of DALSA's web site. For a downloadable image of Xineos, please visit our online media kit. To learn more about emerging digital technologies for X-ray imaging, download our technology primer on CMOS detectors for X-ray imaging.
About DALSA's Life Sciences Products and Services
DALSA provides state-of-the-art image sensing, capture and processing solutions to medical, dental and scientific equipment manufacturers. Building on 30 years of proven capability and innovation, our highly skilled team of imaging specialists adds value with their continued focus on leading-edge product design. Our manufacturing processes are tailored to comply with the stringent quality, reliability and traceability requirements of the medical and scientific X-ray community.
About DALSA Corporation
DALSA (TSX: DSA) is an international leader in high performance digital imaging and semiconductors with approximately 1000 employees worldwide, headquartered in Waterloo, Ontario, Canada. Established in 1980, the company designs, develops, manufactures and markets digital imaging products and solutions, in addition to providing semiconductor products and services.
Xineos uses DALSA's proprietary CMOS technology to deliver three times more sensitivity and five times more signal-to-noise performance than other standard technologies at equal X-ray dose.